<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-4c18-79df-014c-2d6dc6ce0a53</uuid><title>Venous Thromboembolism Prophylaxis</title><shortTitle>Venous Thromboembolism Prophyla</shortTitle><emeasureid>108</emeasureid><guid>38b0b5ec-0f63-466f-8fe3-2cd20ddd1622</guid><version>4.0.000</version><nqfid extension="0371" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="40280381-3d27-5493-013d-4be146945c78"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="1.3.6.1.4.1.33895">The Joint Commission</steward><developers><developer id="1.3.6.1.4.1.33895">The Joint Commission</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>This measure assesses the number of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission.</description><copyright>Measure specifications are in the Public Domain&#xD;
&#xD;
LOINC(R) is a registered trademark of the Regenstrief Institute.&#xD;
&#xD;
This material contains SNOMED Clinical Terms (R) (SNOMED CT[C]) copyright 2004-2014 International Health Terminology Standards Development Organization. All rights reserved.</copyright><disclaimer>These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The measures and specifications are provided without warranty</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><componentMeasures/><itemCount><elementRef dataType="Encounter, Performed" id="d02dd7f9-4e29-4b23-ab45-1c3ec4a08093" name="Encounter Inpatient" oid="2.16.840.1.113883.3.666.5.307"/></itemCount><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>Hospitalized patients at high-risk for VTE may develop an asymptomatic deep vein thrombosis (DVT), and die from pulmonary embolism (PE) even before the diagnosis is suspected. The majority of fatal events occur as sudden or abrupt death, underscoring the importance of prevention as the most critical action step for reducing death from PE (Geerts, et al, 2008).&#xD;
&#xD;
The estimated annual incidence of deep-vein thrombosis (DVT) and pulmonary embolism (PE), known collectively as venous thromboembolism (VTE), is approximately 900,000 (Geerts, et al, 2008). Approximately two-thirds of cases of DVT or PE are associated with recent hospitalization. This is consistent with the 2001 report by The Agency for Healthcare Research and Quality (AHRQ). AHRQ indicates that "the appropriate application of effective preventive measures in hospitals has major potential for improving patient safety by reducing the incidence of venous thromboembolism" (Shojania, 2001).&#xD;
&#xD;
Despite its proven effectiveness, rates of appropriate thromboprophylaxis remain low in both medical and surgical patients. A recent analysis from the ENDORSE survey, which evaluated prophylaxis rates in 17,084 major surgery patients, found that more than one third of patients at risk for VTE (38%) did not receive prophylaxis and that rates varied by surgery type (Cohen, et al., 2008).&#xD;
&#xD;
In a review of evidence-based patient safety practices, the Agency for Healthcare Research and Quality defined thromboprophylaxis against VTE as the "number one patient safety practice" for hospitalized patients (Shojania, 2001). Updated "safe practices" published by the National Quality Forum (NQF) recommend routine evaluation of hospitalized patients for risk of VTE and use of appropriate prophylaxis (National Quality Forum. National Voluntary Consensus Standards for Prevention and Care of Venous Thromboembolism, 2006).&#xD;
&#xD;
As noted by the ACCP, a vast number of randomized clinical trials provide irrefutable evidence that thromboprophylaxis reduces VTE events, and there are studies that have also shown that fatal PE is prevented by thromboprophylaxis (Geerts, et al. 2008).&#xD;
&#xD;
Some select surgeries have previously been monitored in the Surgical Care Improvement Project; since performance on these surgeries has achieved very high levels, they are not included in this measure.</rationale><recommendations>Failure to recognize and protect patients at risk for venous thromboembolism (VTE) increases the chances for acutely ill hospitalized patients at high risk for developing a deep vein thrombosis or dying from a pulmonary emboli. Screening all patients is the only evidence based practice in reducing incidence of disease.  All hospitalized patients should be evaluated for primary VTE prophylaxis, and given appropriate prophylaxis when indicated.</recommendations><improvementNotations>Improvement noted as an increase in rate</improvementNotations><references><reference>Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387-394.</reference><reference>Geerts  WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism. The Eighth ACCP Conference on antithrombotic and thrombolytic therapy. Chest. 2008; 133:381S-453S</reference><reference>Guyatt, G.H., Akl, E.A., Crowther, M., Gutterman, D., Schunemann, H. Antithrombotic Therapy and Prevention of Thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST 2012; 141(2)(Supp):7S-47S</reference><reference>Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th Edition: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. CHEST 2012 Feb; 141(2) (Supp):e419S-94S. </reference><reference>National Quality Forum. National Voluntary Consensus Standards for Prevention and Care of Venous Thromboembolism: Policy, Preferred Practices, and Initial Performance Measures. A Consensus Report. Washington, DC. NQF; 2006</reference><reference>Shojania KG, Duncan BW, McDonald DM, et al. (Eds.). (2001). Making healthcare safer; A critical analysis of patient safety practices (Evidence Report/Technology Assessment No. 43). Prepared by the University of California at San Francisco-Stanford Evidenced-based Practice Center under Contract no. 290-97-0013 (AHRQ Publication NO.01-E058). Rockville, MD:Agency for Healthcare Research and Quality.</reference></references><definitions>None</definitions><guidance>The unit of measurement for this measure is an inpatient episode of care. Each distinct hospitalization should be reported, regardless of whether the same patient is admitted for inpatient care more than once during the measurement period. In addition, the eMeasure logic intends to represent events within or surrounding a single occurrence of an inpatient hospitalization.&#xD;
&#xD;
When low dose unfractionated heparin is not administered due to medical reasons, the intended administration route is subcutaneous.&#xD;
&#xD;
The construct of Unfractionated Heparin (route: 'Intravenous route') intends to capture continually infused heparin rather than heparin flushes or pushes.</guidance><transmissionFormat>TBD</transmissionFormat><initialPopDescription>Patients age 18 and older discharged during the measurement period from hospital inpatient acute care with a length of stay less than or equal to 120 days, without a diagnosis of venous thromboembolism (VTE) or obstetrics. </initialPopDescription><denominatorDescription>All patients in the initial population</denominatorDescription><denominatorExclusionsDescription>Patients who have a length of stay less than 2 days&#xD;
Patients with comfort measures documented anytime between arrival and the day after hospital admission&#xD;
Patients with comfort measures documented by the day after surgery end date for surgeries that start the day of or the day after hospital admission&#xD;
Patients who are direct admits to intensive care unit (ICU), or transferred to ICU the day of or the day after hospital admission with ICU length of stay greater than or equal to one day&#xD;
Patients with a principal diagnosis of mental disorders or stroke&#xD;
Patients with a principal procedure of Surgical Care Improvement Project (SCIP) VTE selected surgeries</denominatorExclusionsDescription><numeratorDescription>Patients who received VTE prophylaxis:&#xD;
-the day of or the day after hospital admission&#xD;
-the day of or the day after surgery end date for surgeries that end the day of or the day after hospital admission&#xD;
&#xD;
Patients who have documentation of a reason why no VTE prophylaxis was given:&#xD;
- between arrival and hospital admission&#xD;
- the day of or the day after hospital admission&#xD;
- the day of or the day after surgery end date (for surgeries that end the day of or the day after hospital admission)</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>None</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measurePopulationExclusionsDescription>Not Applicable</measurePopulationExclusionsDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="0ddd5331-22f1-404c-aac6-10be6025c97f">eMeasure Venous Thromboembolism (eVTE)</qualityMeasureSet>
<finalizedDate value="201504011026-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3d27-5493-013d-4be146935c5f" name="ONC Administrative Sex"/><elementRef id="40280381-3d27-5493-013d-4be146935c60" name="Race"/><elementRef id="40280381-3d27-5493-013d-4be146935c61" name="Ethnicity"/><elementRef id="40280381-3d27-5493-013d-4be146935c62" name="Payer"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="EncounterInpatient" qdmVariable="true" uuid="448BCEBA-E9F9-44F8-BBC6-825135D35638"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="d02dd7f9-4e29-4b23-ab45-1c3ec4a08093" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="d02dd7f9-4e29-4b23-ab45-1c3ec4a08093" type="qdm"><attribute attrUUID="3c705bc3-a02f-47e4-9c99-cfdd9915ab48" comparisonValue="120" mode="Less Than Or Equal To" name="length of stay" unit="days"/></elementRef><relationalOp displayName="Ends During" type="EDU"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="d02dd7f9-4e29-4b23-ab45-1c3ec4a08093" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d27-5493-013d-4be146945c78" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="Occurrence A of $EncounterInpatient" instance="A" instanceOf="448BCEBA-E9F9-44F8-BBC6-825135D35638" qdmVariable="true" uuid="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="d02dd7f9-4e29-4b23-ab45-1c3ec4a08093" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="d02dd7f9-4e29-4b23-ab45-1c3ec4a08093" type="qdm"><attribute attrUUID="3c705bc3-a02f-47e4-9c99-cfdd9915ab48" comparisonValue="120" mode="Less Than Or Equal To" name="length of stay" unit="days"/></elementRef><relationalOp displayName="Ends During" type="EDU"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="d02dd7f9-4e29-4b23-ab45-1c3ec4a08093" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d27-5493-013d-4be146945c78" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="MedicationVTEProphylaxis" qdmVariable="true" uuid="6AD22E7A-B803-443A-9C78-0E1D08DF04CF"><setOp displayName="UNION" type="union"><elementRef displayName="Low Dose Unfractionated Heparin for VTE Prophylaxis : Medication, Administered" id="389f98c4-53d0-4562-bfae-02b74a2f8c26" type="qdm"><attribute attrUUID="607bc7e6-cef3-44ff-8d33-28087f42595e" mode="Value Set" name="route" qdmUUID="40280381-3d27-5493-013d-4be146945c85"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c92" type="qdm"/><elementRef displayName="Injectable Factor Xa Inhibitor for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c94" type="qdm"/><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c95" type="qdm"/></setOp></subTree><subTree displayName="DeviceVTEProphylaxis" qdmVariable="true" uuid="C7B1CD74-28FA-468D-82E6-4B810EBE29C0"><setOp displayName="UNION" type="union"><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Applied" id="40280381-3d27-5493-013d-4be146945c83" type="qdm"/><elementRef displayName="Venous foot pumps (VFP) : Device, Applied" id="40280381-3d27-5493-013d-4be146945c82" type="qdm"/><elementRef displayName="Graduated compression stockings (GCS) : Device, Applied" id="40280381-3d27-5493-013d-4be146945c81" type="qdm"/></setOp></subTree><subTree displayName="NoMedicationVTEProphylaxisMedicalReason" qdmVariable="true" uuid="4538D7A3-2BFA-4F88-8B29-D187009862DA"><setOp displayName="UNION" type="union"><elementRef displayName="Low Dose Unfractionated Heparin for VTE Prophylaxis : Medication, Administered" id="389f98c4-53d0-4562-bfae-02b74a2f8c26" type="qdm"><attribute attrUUID="13ecc816-dba3-4712-a103-c9eb3531bf3a" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c92" type="qdm"><attribute attrUUID="fc88dc79-7015-4893-98e5-6e702be1c5e5" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Injectable Factor Xa Inhibitor for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c94" type="qdm"><attribute attrUUID="deff5164-7a29-471b-ad73-15d4dd08a066" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c95" type="qdm"><attribute attrUUID="d9db0866-71d9-4d04-9922-353affe8061a" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Unfractionated Heparin for VTE prophylaxis ingredient specific : Medication, Order" id="90715584-52a9-4adc-bd33-c0b993d8eb79" type="qdm"><attribute attrUUID="b9a3cd56-b35a-4a9e-bdfc-238aba8c7f4b" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE prophylaxis ingredient specific : Medication, Order" id="0e4b2de5-1aa7-423a-8b28-a377d23121f0" type="qdm"><attribute attrUUID="27e3ac8c-ab3c-45f0-9ee3-408d2ded2daa" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Injectable factor Xa inhibitor for VTE prophylaxis ingredient specific : Medication, Order" id="1bfbe43a-c32d-4512-9c54-fcc6de810cfe" type="qdm"><attribute attrUUID="c5e2c166-7a66-44f7-8b5c-38ad8522a6c1" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Warfarin-only ingredient specific : Medication, Order" id="02ae2c23-4531-4840-b744-1236ff7db418" type="qdm"><attribute attrUUID="0544004a-f889-45f5-a005-82bfafb5e3e5" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef></setOp></subTree><subTree displayName="NoDeviceVTEProphylaxisMedicalReason" qdmVariable="true" uuid="93AD4DE5-3B1E-4E9E-87B1-8C20A93D9561"><setOp displayName="UNION" type="union"><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Applied" id="40280381-3d27-5493-013d-4be146945c83" type="qdm"><attribute attrUUID="eee59b8c-d446-4256-8ebb-ebdabad516ec" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Venous foot pumps (VFP) : Device, Applied" id="40280381-3d27-5493-013d-4be146945c82" type="qdm"><attribute attrUUID="c44bed35-7c3f-4a33-81bb-9d8efe9900c1" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Graduated compression stockings (GCS) : Device, Applied" id="40280381-3d27-5493-013d-4be146945c81" type="qdm"><attribute attrUUID="ca9ddb3a-1f14-49e7-bbba-da638333d09b" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Order" id="f39e4da2-1572-42d9-823a-47a4ca8efe78" type="qdm"><attribute attrUUID="2cbf0673-2c8c-4b1a-9cc4-56ccd2d26eb8" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Venous foot pumps (VFP) : Device, Order" id="e5357b24-e3a3-4352-9069-aab941adf5a4" type="qdm"><attribute attrUUID="7f8d8164-b353-4aba-9e6f-270c06bdd505" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef><elementRef displayName="Graduated compression stockings (GCS) : Device, Order" id="43de2966-9845-4e0c-bc12-1b541a75f4a3" type="qdm"><attribute attrUUID="877f7ad5-238b-4d63-90d0-7ce7c8d3ec35" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146945c89"/></elementRef></setOp></subTree><subTree displayName="Age GTET 18 years at Occ A EncIP" qdmVariable="false" uuid="5251E914-48A2-4148-9915-62C05B262A4A"><functionalOp displayName="Age &gt;= 18 years at" operatorType="Greater Than or Equal To" quantity="18" type="AGE AT" unit="years"><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></functionalOp></subTree><subTree displayName="Intersection of Occ A EncIP Enc Perf Enc IP LOS LT 2 d" qdmVariable="false" uuid="E2B785C2-0B23-42CA-83B2-D3D42CA67E87"><setOp displayName="INTERSECTION" type="intersection"><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="d02dd7f9-4e29-4b23-ab45-1c3ec4a08093" type="qdm"><attribute attrUUID="2518c016-b301-41cd-bb3e-7a41054cab64" comparisonValue="2" mode="Less Than" name="length of stay" unit="days"/></elementRef></setOp></subTree><subTree displayName="InterventionComfortMeasures" qdmVariable="true" uuid="F3F04188-17CE-488D-AB8E-DC7E9BBBE5D1"><setOp displayName="UNION" type="union"><elementRef displayName="Comfort Measures  : Intervention, Order" id="700ac933-507e-4e59-bec8-e2877c2a07da" type="qdm"/><elementRef displayName="Comfort Measures  : Intervention, Performed" id="3eb39d1f-8e78-4517-becd-d4f62572a882" type="qdm"/></setOp></subTree><subTree displayName="Union of Dx Active Mental Hem Isch Stk Principal starts during OccA EncIP" qdmVariable="false" uuid="08480DDA-2965-469F-B816-25C78A6820A2"><relationalOp displayName="Starts During" type="SDU"><setOp displayName="UNION" type="union"><elementRef displayName="Mental Disorders : Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c6f" type="qdm"><attribute attrUUID="5cb2b991-c0c7-4ee6-bb6e-31cd38a151b4" mode="Value Set" name="ordinality" qdmUUID="40280381-3d27-5493-013d-4be146955c90"/></elementRef><elementRef displayName="Hemorrhagic Stroke : Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c7a" type="qdm"><attribute attrUUID="59015568-e684-4355-9907-168bd036effa" mode="Value Set" name="ordinality" qdmUUID="40280381-3d27-5493-013d-4be146955c90"/></elementRef><elementRef displayName="Ischemic Stroke : Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c70" type="qdm"><attribute attrUUID="cf6fa7cd-1975-47fa-848a-8f4d4fe538f2" mode="Value Set" name="ordinality" qdmUUID="40280381-3d27-5493-013d-4be146955c90"/></elementRef></setOp><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="Union of Proc Perf Gen Surg thru Urologic Surg Principal during OccA EncIP" qdmVariable="false" uuid="5161FDA9-0767-4D0D-8642-C47C90921786"><relationalOp displayName="During" type="DURING"><setOp displayName="UNION" type="union"><elementRef displayName="General Surgery : Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c72" type="qdm"><attribute attrUUID="84ac153c-7e28-48d5-bead-6637a7aed265" mode="Value Set" name="ordinality" qdmUUID="40280381-3d27-5493-013d-4be146955c90"/></elementRef><elementRef displayName="Gynecological Surgery : Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c74" type="qdm"><attribute attrUUID="013d88d4-78b0-4624-bcb8-baea48486de1" mode="Value Set" name="ordinality" qdmUUID="40280381-3d27-5493-013d-4be146955c90"/></elementRef><elementRef displayName="Hip Fracture Surgery : Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c77" type="qdm"><attribute attrUUID="44369847-a8b8-4262-bb02-d8cfca95471b" mode="Value Set" name="ordinality" qdmUUID="40280381-3d27-5493-013d-4be146955c90"/></elementRef><elementRef displayName="Hip Replacement Surgery : Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c75" type="qdm"><attribute attrUUID="1a8ae372-f4af-4124-a914-135fc5f2b096" mode="Value Set" name="ordinality" qdmUUID="40280381-3d27-5493-013d-4be146955c90"/></elementRef><elementRef displayName="Intracranial Neurosurgery : Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c71" type="qdm"><attribute attrUUID="1f919320-8440-40ba-8485-ced0b54bd9a2" mode="Value Set" name="ordinality" qdmUUID="40280381-3d27-5493-013d-4be146955c90"/></elementRef><elementRef displayName="Knee Replacement Surgery : Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c76" type="qdm"><attribute attrUUID="a81b3ede-018f-4d06-a4f3-1fc91cc9edf8" mode="Value Set" name="ordinality" qdmUUID="40280381-3d27-5493-013d-4be146955c90"/></elementRef><elementRef displayName="Urological Surgery : Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c73" type="qdm"><attribute attrUUID="c8fd089e-b82c-48fe-a8c8-a4397f2a3f47" mode="Value Set" name="ordinality" qdmUUID="40280381-3d27-5493-013d-4be146955c90"/></elementRef></setOp><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="Proc Perf General or Neuraxial Anesthesia LTET 1 d EAS Occ A EncIP" qdmVariable="false" uuid="1633FA63-EE9D-4663-90B5-143372051756"><relationalOp displayName="&lt;= 1 days Ends After Start Of" operatorType="Less Than or Equal To" quantity="1" type="EAS" unit="days"><elementRef displayName="General or Neuraxial Anesthesia : Procedure, Performed" id="6640ed6e-22d6-4c14-bbd2-19b08d67ca81" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="NoMedVTEProphylMedReason LTET 1 d SAS Occ A EncIP" qdmVariable="false" uuid="EFEC13A2-3EF3-4418-A45D-D6B376CCF1FA"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><subTreeRef displayName="NoMedicationVTEProphylaxisMedicalReason" id="4538D7A3-2BFA-4F88-8B29-D187009862DA" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="NoDeviceVTEProphMedReason LTET 1 d SAS Occ A EncIP" qdmVariable="false" uuid="415A2ED7-E470-494A-A91E-4EC78812EE25"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><subTreeRef displayName="NoDeviceVTEProphylaxisMedicalReason" id="93AD4DE5-3B1E-4E9E-87B1-8C20A93D9561" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="NoDeviceVTEProphMedReason LTET 1 d SAE GenNeur Anesth LTET 1 d EAS OccA Enc" qdmVariable="false" uuid="907C8115-BB88-4602-A0D9-0A1BB8662C22"><relationalOp displayName="&lt;= 1 days Starts After End Of" operatorType="Less Than or Equal To" quantity="1" type="SAE" unit="days"><subTreeRef displayName="NoDeviceVTEProphylaxisMedicalReason" id="93AD4DE5-3B1E-4E9E-87B1-8C20A93D9561" type="subTree"/><subTreeRef displayName="Proc Perf General or Neuraxial Anesthesia LTET 1 d EAS Occ A EncIP" id="1633FA63-EE9D-4663-90B5-143372051756" type="subTree"/></relationalOp></subTree><subTree displayName="NoMedVTEProphMedReason LTET 1 d SAE GenNeur Anesth LTET 1 d EAS OccA Enc" qdmVariable="false" uuid="05D3E3A5-4899-4408-8B10-57E79EF70E56"><relationalOp displayName="&lt;= 1 days Starts After End Of" operatorType="Less Than or Equal To" quantity="1" type="SAE" unit="days"><subTreeRef displayName="NoMedicationVTEProphylaxisMedicalReason" id="4538D7A3-2BFA-4F88-8B29-D187009862DA" type="subTree"/><subTreeRef displayName="Proc Perf General or Neuraxial Anesthesia LTET 1 d EAS Occ A EncIP" id="1633FA63-EE9D-4663-90B5-143372051756" type="subTree"/></relationalOp></subTree><subTree displayName="NoMedVTEProphMedReason starts during OccA ED LTET 1h EBS OccA EncIP" qdmVariable="false" uuid="9D42A7F9-DD12-4A08-B4EB-D35347986D29"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="NoMedicationVTEProphylaxisMedicalReason" id="4538D7A3-2BFA-4F88-8B29-D187009862DA" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" id="D2D44248-9B81-4F24-96CC-7076FBAF8D86" type="subTree"/></relationalOp></subTree><subTree displayName="NoDeviceVTEProphMedReason starts during OccA ED LTET 1h EBS OccA EncIP" qdmVariable="false" uuid="518456A8-2615-4E8B-B0FF-7446C5914C89"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="NoDeviceVTEProphylaxisMedicalReason" id="93AD4DE5-3B1E-4E9E-87B1-8C20A93D9561" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" id="D2D44248-9B81-4F24-96CC-7076FBAF8D86" type="subTree"/></relationalOp></subTree><subTree displayName="Med Adm Oral Factor Xa Inhib sat any LTET 1d SAS OccA EncIP LTET 1d SAE Ane" qdmVariable="false" uuid="9CD11D9F-457A-4D1D-9EE8-C4BF318FD1EC"><functionalOp displayName="SATISFIES ANY" type="SATISFIES ANY"><elementRef displayName="Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment : Medication, Administered" id="40280381-3d27-5493-013d-4be146935c5b" type="qdm"/><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><elementRef displayName="Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment : Medication, Administered" id="40280381-3d27-5493-013d-4be146935c5b" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp><relationalOp displayName="&lt;= 1 days Starts After End Of" operatorType="Less Than or Equal To" quantity="1" type="SAE" unit="days"><elementRef displayName="Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment : Medication, Administered" id="40280381-3d27-5493-013d-4be146935c5b" type="qdm"/><subTreeRef displayName="Proc Perf General or Neuraxial Anesthesia LTET 1 d EAS Occ A EncIP" id="1633FA63-EE9D-4663-90B5-143372051756" type="subTree"/></relationalOp></functionalOp></subTree><subTree displayName="Union of Dx Inactive AFib Flutter Dx Active Inactive VTE SBS Occ A Enc IP" qdmVariable="false" uuid="4AF9F380-0735-4D5C-B887-3C69E46CFEDD"><relationalOp displayName="Starts Before Start Of" type="SBS"><setOp displayName="UNION" type="union"><elementRef displayName="Atrial Fibrillation/Flutter : Diagnosis, Inactive" id="40280381-3d27-5493-013d-4be146935c5d" type="qdm"/><elementRef displayName="Venous Thromboembolism : Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c67" type="qdm"/><elementRef displayName="Venous Thromboembolism : Diagnosis, Inactive" id="40280381-3d27-5493-013d-4be146935c5e" type="qdm"/></setOp><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="DiagnosisVTE" qdmVariable="true" uuid="F94C0E77-DF10-4434-857F-A3D4C6B76638"><setOp displayName="UNION" type="union"><elementRef displayName="Venous Thromboembolism : Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c67" type="qdm"/><elementRef displayName="Obstetrics VTE : Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c66" type="qdm"/></setOp></subTree><subTree displayName="Union of Dx Active Obstetrics Ob VTE VTE starts during Occ A EncIP" qdmVariable="false" uuid="1D535B0A-ADC5-4C5F-8014-185391D6D5F8"><relationalOp displayName="Starts During" type="SDU"><setOp displayName="UNION" type="union"><elementRef displayName="Obstetrics : Diagnosis, Active" id="40280381-3d27-5493-013d-4be146935c65" type="qdm"/><subTreeRef displayName="DiagnosisVTE" id="F94C0E77-DF10-4434-857F-A3D4C6B76638" type="subTree"/></setOp><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="NoVTEProphylaxisPatientRefusal" qdmVariable="true" uuid="B1F081CD-886F-4559-8A87-134B83060EC7"><setOp displayName="UNION" type="union"><elementRef displayName="Low Dose Unfractionated Heparin for VTE Prophylaxis : Medication, Administered" id="389f98c4-53d0-4562-bfae-02b74a2f8c26" type="qdm"><attribute attrUUID="0ee5d79c-805d-4025-9a61-a4d491dda8b0" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c92" type="qdm"><attribute attrUUID="6c445ad7-d6c5-4432-9396-357e27be88a8" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Injectable Factor Xa Inhibitor for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c94" type="qdm"><attribute attrUUID="7df5ab3c-fdda-4790-b86f-46ae1513e02e" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c95" type="qdm"><attribute attrUUID="467b1836-68bc-4172-92b7-5ef406179b2d" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Unfractionated Heparin for VTE prophylaxis ingredient specific : Medication, Order" id="90715584-52a9-4adc-bd33-c0b993d8eb79" type="qdm"><attribute attrUUID="f30716ef-3248-4bd1-b09e-b56b32016a61" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE prophylaxis ingredient specific : Medication, Order" id="0e4b2de5-1aa7-423a-8b28-a377d23121f0" type="qdm"><attribute attrUUID="91f41ed1-0a4c-49b3-921c-7c3833c110d2" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Injectable factor Xa inhibitor for VTE prophylaxis ingredient specific : Medication, Order" id="1bfbe43a-c32d-4512-9c54-fcc6de810cfe" type="qdm"><attribute attrUUID="bde884fa-96e5-4b25-954c-b7ceef3d3499" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Warfarin-only ingredient specific : Medication, Order" id="02ae2c23-4531-4840-b744-1236ff7db418" type="qdm"><attribute attrUUID="457289cb-50c9-41c0-a942-ba4ef405db2c" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Applied" id="40280381-3d27-5493-013d-4be146945c83" type="qdm"><attribute attrUUID="aae02acb-533f-40c1-b6d6-402f99dfed0d" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Venous foot pumps (VFP) : Device, Applied" id="40280381-3d27-5493-013d-4be146945c82" type="qdm"><attribute attrUUID="1b769b0c-8b09-4f6c-abb8-75e242030f63" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Graduated compression stockings (GCS) : Device, Applied" id="40280381-3d27-5493-013d-4be146945c81" type="qdm"><attribute attrUUID="2eaf409b-9a08-4629-b1e2-178d79935899" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Order" id="f39e4da2-1572-42d9-823a-47a4ca8efe78" type="qdm"><attribute attrUUID="dccb4553-68f7-47ef-acc4-2f5f54df7db7" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Venous foot pumps (VFP) : Device, Order" id="e5357b24-e3a3-4352-9069-aab941adf5a4" type="qdm"><attribute attrUUID="5d05c92c-d976-42f8-9642-0ca1ce2822ff" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef><elementRef displayName="Graduated compression stockings (GCS) : Device, Order" id="43de2966-9845-4e0c-bc12-1b541a75f4a3" type="qdm"><attribute attrUUID="44b91529-ebed-46df-b3dc-538483fa5d77" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-4be146955c8a"/></elementRef></setOp></subTree><subTree displayName="InterventionComfortMsrs LTET 1d SAS Occ A EncIP" qdmVariable="false" uuid="81991E5C-56DB-42FF-A7ED-9807C121E88A"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><subTreeRef displayName="InterventionComfortMeasures" id="F3F04188-17CE-488D-AB8E-DC7E9BBBE5D1" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="InterventionComfortMsrs LTET 1d SAE Proc Perf Anesth LTET 1d EAS OccA EncIP" qdmVariable="false" uuid="2E8DBFE6-9059-462E-84D8-7D492FEE66CF"><relationalOp displayName="&lt;= 1 days Starts After End Of" operatorType="Less Than or Equal To" quantity="1" type="SAE" unit="days"><subTreeRef displayName="InterventionComfortMeasures" id="F3F04188-17CE-488D-AB8E-DC7E9BBBE5D1" type="subTree"/><subTreeRef displayName="Proc Perf General or Neuraxial Anesthesia LTET 1 d EAS Occ A EncIP" id="1633FA63-EE9D-4663-90B5-143372051756" type="subTree"/></relationalOp></subTree><subTree displayName="Enc Perf ICU Adm or Transfer LOS GTET 1 d LTET 1 d SAS Occ A EncIP" qdmVariable="false" uuid="EC2FEA49-90EE-4289-B35B-4DE3E6C55158"><relationalOp displayName="&lt;= 1 days Starts After Or Concurrent With Start Of" operatorType="Less Than or Equal To" quantity="1" type="SASORSCW" unit="days"><elementRef displayName="ICU Admission or Transfer : Encounter, Performed" id="40280381-3d27-5493-013d-4be146955c8b" type="qdm"><attribute attrUUID="5aaf8227-ac61-4656-89bc-00bb678e85d0" comparisonValue="1" mode="Greater Than Or Equal To" name="length of stay" unit="days"/></elementRef><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="Union of 7 Prophylaxis variable statements" qdmVariable="false" uuid="4252CF2B-A1D7-4EDB-8104-5F5852F41286"><setOp displayName="UNION" type="union"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><subTreeRef displayName="MedicationVTEProphylaxis" id="6AD22E7A-B803-443A-9C78-0E1D08DF04CF" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp><relationalOp displayName="&lt;= 1 days Starts After End Of" operatorType="Less Than or Equal To" quantity="1" type="SAE" unit="days"><subTreeRef displayName="MedicationVTEProphylaxis" id="6AD22E7A-B803-443A-9C78-0E1D08DF04CF" type="subTree"/><subTreeRef displayName="Proc Perf General or Neuraxial Anesthesia LTET 1 d EAS Occ A EncIP" id="1633FA63-EE9D-4663-90B5-143372051756" type="subTree"/></relationalOp><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><subTreeRef displayName="DeviceVTEProphylaxis" id="C7B1CD74-28FA-468D-82E6-4B810EBE29C0" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp><relationalOp displayName="&lt;= 1 days Starts After End Of" operatorType="Less Than or Equal To" quantity="1" type="SAE" unit="days"><subTreeRef displayName="DeviceVTEProphylaxis" id="C7B1CD74-28FA-468D-82E6-4B810EBE29C0" type="subTree"/><subTreeRef displayName="Proc Perf General or Neuraxial Anesthesia LTET 1 d EAS Occ A EncIP" id="1633FA63-EE9D-4663-90B5-143372051756" type="subTree"/></relationalOp></setOp></subTree><subTree displayName="Union of UnfracHep INR VTE Low Risk Direct Throm Glyc LTET 1d SAS OccAEncIP" qdmVariable="false" uuid="52C50E5A-9546-41B3-BA54-DDB1E343B7B7"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><setOp displayName="UNION" type="union"><elementRef displayName="VTE Risk Assessment : Risk Category Assessment" id="40280381-3d27-5493-013d-4be146955c8c" type="qdm"><attribute attrUUID="98e3c165-7aca-43ea-99fe-86bacddb6ec1" mode="Value Set" name="result" qdmUUID="40280381-3d27-5493-013d-4be146955c8f"/></elementRef><elementRef displayName="INR : Laboratory Test, Performed" id="40280381-3d27-5493-013d-4be146945c86" type="qdm"><attribute attrUUID="fdbb4c4c-be24-4375-977b-537d5150ce0a" comparisonValue="3.0" mode="Greater Than" name="result"/></elementRef><elementRef displayName="Unfractionated Heparin : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c91" type="qdm"><attribute attrUUID="40be2de2-dbf9-414e-9723-8e6dbad65098" mode="Value Set" name="route" qdmUUID="40280381-3d27-5493-013d-4be146945c84"/></elementRef><elementRef displayName="Direct Thrombin Inhibitor : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c93" type="qdm"/><elementRef displayName="Glycoprotein IIb/IIIa Inhibitors : Medication, Administered" id="255893d5-bf16-4b8f-93c2-7f5b708aa666" type="qdm"/></setOp><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="Union of UnfracHep thru Glycoprotein LTET 1d SAE GenNeur Anes LTET 1d EAS E" qdmVariable="false" uuid="F7586836-DCB6-4B87-AAF5-221D1ECE9A8C"><relationalOp displayName="&lt;= 1 days Starts After End Of" operatorType="Less Than or Equal To" quantity="1" type="SAE" unit="days"><setOp displayName="UNION" type="union"><elementRef displayName="VTE Risk Assessment : Risk Category Assessment" id="40280381-3d27-5493-013d-4be146955c8c" type="qdm"><attribute attrUUID="552f292c-f6e3-4f58-954b-761fd09307e0" mode="Value Set" name="result" qdmUUID="40280381-3d27-5493-013d-4be146955c8f"/></elementRef><elementRef displayName="INR : Laboratory Test, Performed" id="40280381-3d27-5493-013d-4be146945c86" type="qdm"><attribute attrUUID="59550555-fb17-477e-9648-a45f20cc6ba9" comparisonValue="3.0" mode="Greater Than" name="result"/></elementRef><elementRef displayName="Unfractionated Heparin : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c91" type="qdm"><attribute attrUUID="8b436d2d-9438-4b39-a3a0-e8489d13aba6" mode="Value Set" name="route" qdmUUID="40280381-3d27-5493-013d-4be146945c84"/></elementRef><elementRef displayName="Direct Thrombin Inhibitor : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c93" type="qdm"/><elementRef displayName="Glycoprotein IIb/IIIa Inhibitors : Medication, Administered" id="255893d5-bf16-4b8f-93c2-7f5b708aa666" type="qdm"/></setOp><subTreeRef displayName="Proc Perf General or Neuraxial Anesthesia LTET 1 d EAS Occ A EncIP" id="1633FA63-EE9D-4663-90B5-143372051756" type="subTree"/></relationalOp></subTree><subTree displayName="Union of Dx Active AFib Flutter Hip Replace Fx Surg SBE Occ A EncIP" qdmVariable="false" uuid="5615395E-A9B7-4B64-A522-D95B540BA0C9"><relationalOp displayName="Starts Before Or Concurrent With End Of" type="SBEORSCWE"><setOp displayName="UNION" type="union"><elementRef displayName="Atrial Fibrillation/Flutter : Diagnosis, Active" id="40280381-3d27-5493-013d-4be146935c5c" type="qdm"/><elementRef displayName="Hip Replacement Surgery : Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c75" type="qdm"/><elementRef displayName="Knee Replacement Surgery : Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c76" type="qdm"/></setOp><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" qdmVariable="false" uuid="D2D44248-9B81-4F24-96CC-7076FBAF8D86"><relationalOp displayName="&lt;= 1 hours Ends Before Or Concurrent With Start Of" operatorType="Less Than or Equal To" quantity="1" type="EBSORECWS" unit="hours"><elementRef displayName="Emergency Department Visit : Encounter, Performed" id="49e2f6da-adcc-4106-90c6-1c92ffa08103" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp></subTree><subTree displayName="InterventionComfortMsrs LTET 1d SAS ED Visit" qdmVariable="false" uuid="3FE04520-3AF3-4223-A8E7-39623680A3D7"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><subTreeRef displayName="InterventionComfortMeasures" id="F3F04188-17CE-488D-AB8E-DC7E9BBBE5D1" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" id="D2D44248-9B81-4F24-96CC-7076FBAF8D86" type="subTree"/></relationalOp></subTree><subTree displayName="INR UnfracHep Glycoprotein starts during ED Visit" qdmVariable="false" uuid="9D1C0913-B378-4AC6-A6B7-84F70304E018"><relationalOp displayName="Starts During" type="SDU"><setOp displayName="UNION" type="union"><elementRef displayName="VTE Risk Assessment : Risk Category Assessment" id="40280381-3d27-5493-013d-4be146955c8c" type="qdm"><attribute attrUUID="24edf10b-8255-4f4c-9ab4-989db77bedc4" mode="Value Set" name="result" qdmUUID="40280381-3d27-5493-013d-4be146955c8f"/></elementRef><elementRef displayName="INR : Laboratory Test, Performed" id="40280381-3d27-5493-013d-4be146945c86" type="qdm"><attribute attrUUID="947ffa05-0cf9-412f-86c8-25a7494726b8" comparisonValue="3.0" mode="Greater Than" name="result"/></elementRef><elementRef displayName="Unfractionated Heparin : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c91" type="qdm"><attribute attrUUID="6be5c925-8221-44b8-8364-69b1226eee77" mode="Value Set" name="route" qdmUUID="40280381-3d27-5493-013d-4be146945c84"/></elementRef><elementRef displayName="Direct Thrombin Inhibitor : Medication, Administered" id="40280381-3d27-5493-013d-4be146955c93" type="qdm"/><elementRef displayName="Glycoprotein IIb/IIIa Inhibitors : Medication, Administered" id="255893d5-bf16-4b8f-93c2-7f5b708aa666" type="qdm"/></setOp><subTreeRef displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" id="D2D44248-9B81-4F24-96CC-7076FBAF8D86" type="subTree"/></relationalOp></subTree><subTree displayName="No VTE Prophylaxis Patient Refusal LTET 1 day" qdmVariable="false" uuid="CC6BB5E1-9D6A-49E4-9C5F-34C602F5FCD7"><setOp displayName="UNION" type="union"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><subTreeRef displayName="NoVTEProphylaxisPatientRefusal" id="B1F081CD-886F-4559-8A87-134B83060EC7" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="B1F367EE-F4B1-4E63-ACFF-C2DF2A86B267" type="subTree"/></relationalOp><relationalOp displayName="&lt;= 1 days Starts After End Of" operatorType="Less Than or Equal To" quantity="1" type="SAE" unit="days"><subTreeRef displayName="NoVTEProphylaxisPatientRefusal" id="B1F081CD-886F-4559-8A87-134B83060EC7" type="subTree"/><subTreeRef displayName="Proc Perf General or Neuraxial Anesthesia LTET 1 d EAS Occ A EncIP" id="1633FA63-EE9D-4663-90B5-143372051756" type="subTree"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="NoVTEProphylaxisPatientRefusal" id="B1F081CD-886F-4559-8A87-134B83060EC7" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" id="D2D44248-9B81-4F24-96CC-7076FBAF8D86" type="subTree"/></relationalOp></setOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 1" type="initialPopulation" uuid="B85033B5-D1C0-40FA-9FA4-186BCC322B1C"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age GTET 18 years at Occ A EncIP" id="5251E914-48A2-4148-9915-62C05B262A4A" type="subTree"/><logicalOp displayName="AND NOT" type="andNot"><comment displayName="comment" type="comment"/><subTreeRef displayName="Union of Dx Active Obstetrics Ob VTE VTE starts during Occ A EncIP" id="1D535B0A-ADC5-4C5F-8014-185391D6D5F8" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="A01E3370-C982-4362-9CCB-AEF4438AE069"><logicalOp displayName="AND" type="and"><comment displayName="comment" type="comment"/></logicalOp></clause><clause displayName="Denominator Exclusions 1" type="denominatorExclusions" uuid="4E1B60B5-AA5B-4CEC-99B8-8A2C02F7D771"><logicalOp displayName="OR" type="or"><comment displayName="comment" type="comment"/><subTreeRef displayName="Intersection of Occ A EncIP Enc Perf Enc IP LOS LT 2 d" id="E2B785C2-0B23-42CA-83B2-D3D42CA67E87" type="subTree"/><subTreeRef displayName="Enc Perf ICU Adm or Transfer LOS GTET 1 d LTET 1 d SAS Occ A EncIP" id="EC2FEA49-90EE-4289-B35B-4DE3E6C55158" type="subTree"/><subTreeRef displayName="Union of Dx Active Mental Hem Isch Stk Principal starts during OccA EncIP" id="08480DDA-2965-469F-B816-25C78A6820A2" type="subTree"/><subTreeRef displayName="Union of Proc Perf Gen Surg thru Urologic Surg Principal during OccA EncIP" id="5161FDA9-0767-4D0D-8642-C47C90921786" type="subTree"/><subTreeRef displayName="InterventionComfortMsrs LTET 1d SAS ED Visit" id="3FE04520-3AF3-4223-A8E7-39623680A3D7" type="subTree"/><subTreeRef displayName="InterventionComfortMsrs LTET 1d SAS Occ A EncIP" id="81991E5C-56DB-42FF-A7ED-9807C121E88A" type="subTree"/><subTreeRef displayName="InterventionComfortMsrs LTET 1d SAE Proc Perf Anesth LTET 1d EAS OccA EncIP" id="2E8DBFE6-9059-462E-84D8-7D492FEE66CF" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="5CC2F270-0A64-4EF2-8D29-5BC2DC5A5522"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><comment displayName="comment" type="comment">VTE prophylaxis options</comment><subTreeRef displayName="Union of 7 Prophylaxis variable statements" id="4252CF2B-A1D7-4EDB-8104-5F5852F41286" type="subTree"/><logicalOp displayName="AND" type="and"><comment displayName="comment" type="comment"/><subTreeRef displayName="Med Adm Oral Factor Xa Inhib sat any LTET 1d SAS OccA EncIP LTET 1d SAE Ane" id="9CD11D9F-457A-4D1D-9EE8-C4BF318FD1EC" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="Union of Dx Active AFib Flutter Hip Replace Fx Surg SBE Occ A EncIP" id="5615395E-A9B7-4B64-A522-D95B540BA0C9" type="subTree"/><subTreeRef displayName="Union of Dx Inactive AFib Flutter Dx Active Inactive VTE SBS Occ A Enc IP" id="4AF9F380-0735-4D5C-B887-3C69E46CFEDD" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></logicalOp><subTreeRef displayName="INR UnfracHep Glycoprotein starts during ED Visit" id="9D1C0913-B378-4AC6-A6B7-84F70304E018" type="subTree"><comment displayName="comment" type="comment">Reasons for no VTE prophylaxis</comment></subTreeRef><subTreeRef displayName="Union of UnfracHep INR VTE Low Risk Direct Throm Glyc LTET 1d SAS OccAEncIP" id="52C50E5A-9546-41B3-BA54-DDB1E343B7B7" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef><subTreeRef displayName="Union of UnfracHep thru Glycoprotein LTET 1d SAE GenNeur Anes LTET 1d EAS E" id="F7586836-DCB6-4B87-AAF5-221D1ECE9A8C" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="NoMedVTEProphMedReason starts during OccA ED LTET 1h EBS OccA EncIP" id="9D42A7F9-DD12-4A08-B4EB-D35347986D29" type="subTree"/><subTreeRef displayName="NoDeviceVTEProphMedReason starts during OccA ED LTET 1h EBS OccA EncIP" id="518456A8-2615-4E8B-B0FF-7446C5914C89" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="NoMedVTEProphylMedReason LTET 1 d SAS Occ A EncIP" id="EFEC13A2-3EF3-4418-A45D-D6B376CCF1FA" type="subTree"/><subTreeRef displayName="NoDeviceVTEProphMedReason LTET 1 d SAS Occ A EncIP" id="415A2ED7-E470-494A-A91E-4EC78812EE25" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="NoMedVTEProphMedReason LTET 1 d SAE GenNeur Anesth LTET 1 d EAS OccA Enc" id="05D3E3A5-4899-4408-8B10-57E79EF70E56" type="subTree"/><subTreeRef displayName="NoDeviceVTEProphMedReason LTET 1 d SAE GenNeur Anesth LTET 1 d EAS OccA Enc" id="907C8115-BB88-4602-A0D9-0A1BB8662C22" type="subTree"/></logicalOp><subTreeRef displayName="No VTE Prophylaxis Patient Refusal LTET 1 day" id="CC6BB5E1-9D6A-49E4-9C5F-34C602F5FCD7" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></logicalOp></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="7682691a-6b70-45a8-83d6-4b2407ff2b4e"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="28ed6419-03a7-40e4-ae3a-9bfffef9b548"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="677e2e9a-dd45-4930-9c77-9b532ed6f1ff"/></group></measureGrouping><elementLookUp><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d27-5493-013d-4be146935c5c" name="Atrial Fibrillation/Flutter" oid="2.16.840.1.113883.3.117.1.7.1.202" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146935c5c" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Inactive" id="40280381-3d27-5493-013d-4be146935c5d" name="Atrial Fibrillation/Flutter" oid="2.16.840.1.113883.3.117.1.7.1.202" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146935c5d" version="1"/><qdm datatype="Patient Characteristic Birthdate" id="b46bd7ed-bec1-43bd-aa1c-2f6be5056f23" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="b46bd7ed-bec1-43bd-aa1c-2f6be5056f23" version="1.0"/><qdm datatype="Intervention, Order" id="700ac933-507e-4e59-bec8-e2877c2a07da" name="Comfort Measures " oid="1.3.6.1.4.1.33895.1.3.0.45" suppDataElement="false" taxonomy="SNOMEDCT" uuid="700ac933-507e-4e59-bec8-e2877c2a07da" version="1.0"/><qdm datatype="Intervention, Performed" id="3eb39d1f-8e78-4517-becd-d4f62572a882" name="Comfort Measures " oid="1.3.6.1.4.1.33895.1.3.0.45" suppDataElement="false" taxonomy="SNOMEDCT" uuid="3eb39d1f-8e78-4517-becd-d4f62572a882" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d27-5493-013d-4be146955c93" name="Direct Thrombin Inhibitor" oid="2.16.840.1.113883.3.117.1.7.1.205" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3d27-5493-013d-4be146955c93" version="1"/><qdm datatype="Encounter, Performed" id="49e2f6da-adcc-4106-90c6-1c92ffa08103" name="Emergency Department Visit" oid="2.16.840.1.113883.3.117.1.7.1.292" suppDataElement="false" taxonomy="SNOMEDCT" uuid="49e2f6da-adcc-4106-90c6-1c92ffa08103" version="1.0"/><qdm datatype="Encounter, Performed" id="d02dd7f9-4e29-4b23-ab45-1c3ec4a08093" name="Encounter Inpatient" oid="2.16.840.1.113883.3.666.5.307" suppDataElement="false" taxonomy="SNOMEDCT" uuid="d02dd7f9-4e29-4b23-ab45-1c3ec4a08093" version="1.0"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3d27-5493-013d-4be146935c61" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3d27-5493-013d-4be146935c61" version="1"/><qdm datatype="Patient Characteristic Expired" id="976746a1-32a5-40e0-aea3-1eb198e56991" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="976746a1-32a5-40e0-aea3-1eb198e56991" version="1.0"/><qdm datatype="Procedure, Performed" id="6640ed6e-22d6-4c14-bbd2-19b08d67ca81" name="General or Neuraxial Anesthesia" oid="2.16.840.1.113883.3.666.5.1743" suppDataElement="false" taxonomy="Grouping" uuid="6640ed6e-22d6-4c14-bbd2-19b08d67ca81" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c72" name="General Surgery" oid="2.16.840.1.113883.3.117.1.7.1.255" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c72" version="1"/><qdm datatype="Medication, Administered" id="255893d5-bf16-4b8f-93c2-7f5b708aa666" name="Glycoprotein IIb/IIIa Inhibitors" oid="2.16.840.1.113762.1.4.1045.41" suppDataElement="false" taxonomy="RXNORM" uuid="255893d5-bf16-4b8f-93c2-7f5b708aa666" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Device, Applied" id="40280381-3d27-5493-013d-4be146945c81" name="Graduated compression stockings (GCS)" oid="2.16.840.1.113883.3.117.1.7.1.256" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-4be146945c81" version="1"/><qdm datatype="Device, Order" id="43de2966-9845-4e0c-bc12-1b541a75f4a3" name="Graduated compression stockings (GCS)" oid="2.16.840.1.113883.3.117.1.7.1.256" suppDataElement="false" taxonomy="SNOMEDCT" uuid="43de2966-9845-4e0c-bc12-1b541a75f4a3" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c74" name="Gynecological Surgery" oid="2.16.840.1.113883.3.117.1.7.1.257" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c74" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c7a" name="Hemorrhagic Stroke" oid="2.16.840.1.113883.3.117.1.7.1.212" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c7a" version="1"/><qdm codeSystemName="Joint Commission" datatype="Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c77" name="Hip Fracture Surgery" oid="2.16.840.1.113883.3.117.1.7.1.258" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c77" version="1"/><qdm codeSystemName="Joint Commission" datatype="Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c75" name="Hip Replacement Surgery" oid="2.16.840.1.113883.3.117.1.7.1.259" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c75" version="1"/><qdm codeSystemName="Joint Commission" datatype="Encounter, Performed" id="40280381-3d27-5493-013d-4be146955c8b" name="ICU Admission or Transfer" oid="2.16.840.1.113883.3.117.1.7.1.305" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-4be146955c8b" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d27-5493-013d-4be146955c94" name="Injectable Factor Xa Inhibitor for VTE Prophylaxis" oid="2.16.840.1.113883.3.117.1.7.1.211" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3d27-5493-013d-4be146955c94" version="1"/><qdm datatype="Medication, Order" id="1bfbe43a-c32d-4512-9c54-fcc6de810cfe" name="Injectable factor Xa inhibitor for VTE prophylaxis ingredient specific" oid="2.16.840.1.113762.1.4.1021.11" suppDataElement="false" taxonomy="RXNORM" uuid="1bfbe43a-c32d-4512-9c54-fcc6de810cfe" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Laboratory Test, Performed" id="40280381-3d27-5493-013d-4be146945c86" name="INR" oid="2.16.840.1.113883.3.117.1.7.1.213" suppDataElement="false" taxonomy="LOINC" uuid="40280381-3d27-5493-013d-4be146945c86" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Device, Applied" id="40280381-3d27-5493-013d-4be146945c83" name="Intermittent pneumatic compression devices (IPC)" oid="2.16.840.1.113883.3.117.1.7.1.214" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-4be146945c83" version="1"/><qdm datatype="Device, Order" id="f39e4da2-1572-42d9-823a-47a4ca8efe78" name="Intermittent pneumatic compression devices (IPC)" oid="2.16.840.1.113883.3.117.1.7.1.214" suppDataElement="false" taxonomy="SNOMEDCT" uuid="f39e4da2-1572-42d9-823a-47a4ca8efe78" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c71" name="Intracranial Neurosurgery" oid="2.16.840.1.113883.3.117.1.7.1.260" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c71" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d27-5493-013d-4be146945c84" name="Intravenous route" oid="2.16.840.1.113883.3.117.1.7.1.222" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-4be146945c84" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c70" name="Ischemic Stroke" oid="2.16.840.1.113883.3.117.1.7.1.247" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c70" version="1"/><qdm codeSystemName="Joint Commission" datatype="Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c76" name="Knee Replacement Surgery" oid="2.16.840.1.113883.3.117.1.7.1.261" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c76" version="1"/><qdm datatype="Medication, Administered" id="389f98c4-53d0-4562-bfae-02b74a2f8c26" name="Low Dose Unfractionated Heparin for VTE Prophylaxis" oid="2.16.840.1.113762.1.4.1045.39" suppDataElement="false" taxonomy="RXNORM" uuid="389f98c4-53d0-4562-bfae-02b74a2f8c26" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d27-5493-013d-4be146955c92" name="Low Molecular Weight Heparin for VTE Prophylaxis" oid="2.16.840.1.113883.3.117.1.7.1.219" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3d27-5493-013d-4be146955c92" version="1"/><qdm datatype="Medication, Order" id="0e4b2de5-1aa7-423a-8b28-a377d23121f0" name="Low Molecular Weight Heparin for VTE prophylaxis ingredient specific" oid="2.16.840.1.113762.1.4.1021.12" suppDataElement="false" taxonomy="RXNORM" uuid="0e4b2de5-1aa7-423a-8b28-a377d23121f0" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d27-5493-013d-4be146955c8f" name="Low Risk" oid="2.16.840.1.113883.3.117.1.7.1.400" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-4be146955c8f" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3d27-5493-013d-4be146945c78" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3d27-5493-013d-4be146945c78" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d27-5493-013d-4be146945c89" name="Medical Reason" oid="2.16.840.1.113883.3.117.1.7.1.473" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-4be146945c89" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c6f" name="Mental Disorders" oid="2.16.840.1.113883.3.117.1.7.1.262" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c6f" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d27-5493-013d-4be146935c65" name="Obstetrics" oid="2.16.840.1.113883.3.117.1.7.1.263" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146935c65" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c66" name="Obstetrics VTE" oid="2.16.840.1.113883.3.117.1.7.1.264" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c66" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3d27-5493-013d-4be146935c5f" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="40280381-3d27-5493-013d-4be146935c5f" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d27-5493-013d-4be146935c5b" name="Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment" oid="2.16.840.1.113883.3.117.1.7.1.134" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3d27-5493-013d-4be146935c5b" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d27-5493-013d-4be146955c8a" name="Patient Refusal" oid="2.16.840.1.113883.3.117.1.7.1.93" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-4be146955c8a" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3d27-5493-013d-4be146935c62" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3d27-5493-013d-4be146935c62" version="1"/><qdm codeSystemName="Oklahoma Foundation for Medical Quality" datatype="attribute" id="40280381-3d27-5493-013d-4be146955c90" name="Principal" oid="2.16.840.1.113883.3.117.1.7.1.14" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-4be146955c90" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3d27-5493-013d-4be146935c60" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3d27-5493-013d-4be146935c60" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d27-5493-013d-4be146945c85" name="Subcutaneous route" oid="2.16.840.1.113883.3.117.1.7.1.223" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-4be146945c85" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d27-5493-013d-4be146955c91" name="Unfractionated Heparin" oid="2.16.840.1.113883.3.117.1.7.1.218" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3d27-5493-013d-4be146955c91" version="1"/><qdm datatype="Medication, Order" id="90715584-52a9-4adc-bd33-c0b993d8eb79" name="Unfractionated Heparin for VTE prophylaxis ingredient specific" oid="2.16.840.1.113762.1.4.1021.13" suppDataElement="false" taxonomy="RXNORM" uuid="90715584-52a9-4adc-bd33-c0b993d8eb79" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Procedure, Performed" id="40280381-3d27-5493-013d-4be146945c73" name="Urological Surgery" oid="2.16.840.1.113883.3.117.1.7.1.272" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c73" version="1"/><qdm codeSystemName="Joint Commission" datatype="Device, Applied" id="40280381-3d27-5493-013d-4be146945c82" name="Venous foot pumps (VFP)" oid="2.16.840.1.113883.3.117.1.7.1.230" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-4be146945c82" version="1"/><qdm datatype="Device, Order" id="e5357b24-e3a3-4352-9069-aab941adf5a4" name="Venous foot pumps (VFP)" oid="2.16.840.1.113883.3.117.1.7.1.230" suppDataElement="false" taxonomy="SNOMEDCT" uuid="e5357b24-e3a3-4352-9069-aab941adf5a4" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Inactive" id="40280381-3d27-5493-013d-4be146935c5e" name="Venous Thromboembolism" oid="2.16.840.1.113883.3.117.1.7.1.279" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146935c5e" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d27-5493-013d-4be146945c67" name="Venous Thromboembolism" oid="2.16.840.1.113883.3.117.1.7.1.279" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4be146945c67" version="1"/><qdm codeSystemName="Joint Commission" datatype="Risk Category Assessment" id="40280381-3d27-5493-013d-4be146955c8c" name="VTE Risk Assessment" oid="2.16.840.1.113883.3.117.1.7.1.357" suppDataElement="false" taxonomy="LOINC" uuid="40280381-3d27-5493-013d-4be146955c8c" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d27-5493-013d-4be146955c95" name="Warfarin" oid="2.16.840.1.113883.3.117.1.7.1.232" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3d27-5493-013d-4be146955c95" version="1"/><qdm datatype="Medication, Order" id="02ae2c23-4531-4840-b744-1236ff7db418" name="Warfarin-only ingredient specific" oid="2.16.840.1.113762.1.4.1021.10" suppDataElement="false" taxonomy="RXNORM" uuid="02ae2c23-4531-4840-b744-1236ff7db418" version="1.0"/></elementLookUp></measure>